BMS-182751

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2002
0119982002

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2002
2002
OBJECTIVE BMS-182751 (JM-216) is an orally bioavailable platinum compound with activity in platinum-sensitive and platinum… (More)
Is this relevant?
1999
1999
The rectal absorption of a platinum anti-tumor agent, [bis (acetato) ammine dichloro (cyclohexylamine) platinum(IV)] (BMS-182751… (More)
Is this relevant?
Review
1999
Review
1999
Chemotherapy plays an important role in the palliative treatment of head and neck cancer and in the neoadjuvant setting for… (More)
  • table I
  • table II
  • table III
Is this relevant?
1998
1998
BACKGROUND The oral bis (acetate) ammine dichloro cyclohexylamine platinum (IV) analogue (BMS-182751) was brought into clinical… (More)
Is this relevant?